Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Koboldt

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|October 6, 2011
Cyclooxygenase assaysJ K Gierse, C M Koboldt
The Biochemical Journal|April 24, 1999
Kinetic basis for selective inhibition of cyclo-oxygenasesJ K Gierse, C M Koboldt, M C Walker, et al.
The Journal of Biological Chemistry|June 28, 1996
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitorsJ K Gierse, J J McDonald, S D Hauser, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, D J Rogier, M J Graneto, et al.
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|October 6, 2011
Cyclooxygenase assaysJ K Gierse, C M Koboldt
The Biochemical Journal|April 24, 1999
Kinetic basis for selective inhibition of cyclo-oxygenasesJ K Gierse, C M Koboldt, M C Walker, et al.
The Journal of Biological Chemistry|June 28, 1996
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitorsJ K Gierse, J J McDonald, S D Hauser, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, D J Rogier, M J Graneto, et al.
The Biochemical Journal|July 21, 2001
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsM C Walker, R G Kurumbail, J R Kiefer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Pharmacological analysis of cyclooxygenase-1 in inflammationC J Smith, Y Zhang, C M Koboldt, et al.
Journal of Medicinal Chemistry|May 23, 1997
1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2I K Khanna, R M Weier, Y Yu, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|November 11, 1994
Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitorsD B Reitz, J J Li, M B Norton, et al.
Pageof 2